JP Stock MarketDetailed Quotes

2160 GNI Group

Watchlist
  • 2304
  • -37-1.58%
20min DelayMarket Closed Mar 24 15:10 JST
115.71BMarket Cap108.94P/E (Static)

About GNI Group Company

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

Company Profile

Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees867
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ying Luo, PhD
  • Director, Representative Executive Officer, President and Chief Executive Officer
  • --
  • Toshiya Kitagawa
  • Director, Executive Officer and Chief Financial Officer
  • --
  • Sekitani Kazuki
  • Director, Executive Officer and Chief Operating Officer
  • --
  • Ryosuke Matsui
  • Director
  • --
  • Thomas Eastling
  • Director
  • --
  • Zhang Ping
  • Independent Director
  • --
  • Kikuchi Kanako
  • Independent Director
  • --
  • Hideaki Sashiwa
  • Independent Director
  • --
Top JP Stock Gainers
Symbol Price % Chg
S Science
5721
84 +40.00%
RVH
6786
69 +21.05%
Aun Consulting
2459
484 +19.80%
K Pharma
4896
933 +19.16%
Intertrade
3747
651 +18.15%

See the daily top gainer.